BLCO

BLCO

USD

Bausch + Lomb Corporation Common Shares

$15.550+0.080 (0.517%)

वास्तविक समय मूल्य

Healthcare
Medical Instruments & Supplies
कनाडा

मूल्य चार्ट

Loading Chart...

मुख्य मीट्रिक्स

बाजार मीट्रिक्स
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े

बाजार मीट्रिक्स

खुलना

$15.470

उच्च

$15.554

कम

$15.300

मात्रा

0.81M

कंपनी के मौलिक सिद्धांत

बाजार पूंजीकरण

5.5B

उद्योग

Medical Instruments & Supplies

देश

Canada

ट्रेडिंग आँकड़े

औसत मात्रा

0.52M

एक्सचेंज

NYQ

मुद्रा

USD

52-सप्ताह रेंज

कम $10.45वर्तमान $15.550उच्च $20.712

संबंधित समाचार

BusinessWire

Bausch + Lomb to Hold Investor Day on Nov. 13

Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock

और देखें
Bausch + Lomb to Hold Investor Day on Nov. 13
Analyst Upgrades

Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17

Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and raises the price target from $16 to $17.

और देखें
Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17

HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb with a Buy and raises the price target from $16 to $17.

और देखें
HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16

JP Morgan analyst Robbie Marcus maintains Bausch & Lomb with a Neutral and raises the price target from $13 to $16.

और देखें
JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16
Analyst Upgrades

Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18

Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb with a Outperform and raises the price target from $17 to $18.

और देखें
Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18
Analyst Upgrades

Wells Fargo Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $16

Wells Fargo analyst Larry Biegelsen maintains Bausch & Lomb with a Equal-Weight and raises the price target from $15 to $16.

Analyst Upgrades

Raymond James Reiterates Outperform on Bausch & Lomb, Raises Price Target to $19

Raymond James analyst Gary Nachman reiterates Bausch & Lomb with a Outperform and raises the price target from $18 to $19.

अपडेट रहें

मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।